Published patent application A claims using material B to treat genetic
diseases via Method C. Method C includes using transfection reagents to
deliver B into cells/tissues. All claims are very broad.
Same inventors worked out specific formulations of transfection reagents for
optimal delivery of B. Can a CIP (A is currently pending) or new
application be filed to claim the specific
formulations, provided the formulations are otherwise novel?
thanks！
